4-Bromobenzo[b]thiophene CAS 5118-13-8 Kemurnian >97,0% (GC) Brexpiprazole Intermediate Produsen

Katrangan singkat:

Jeneng Kimia: 4-Bromobenzo[b]thiophene

CAS: 5118-13-8

Kemurnian:> 97,0% (GC)

Penampilan: bubuk padat kuning cahya

Intermediate saka Brexpiprazole (CAS: 913611-97-9)

E-Mail: alvin@ruifuchem.com

Kirimi email kanggo kita

Detail Produk

Produk sing gegandhengan

Tag produk

katrangan:

Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]tiofen CAS 5118-13-8
1-(1-Benzothiophen-4-yl) piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-siji CAS 913613-82-8
4-Chlorobenzo[b]tiofen CAS 66490-33-3

Sifat Kimia:

Jeneng Kimia	4-Bromobenzo[b]tiofen
sinonim	4-Bromobenzothiophene;4-Bromo-Benzo[b]tiofen;4-Bromo-1-Benzothiophene
Nomer CAS	5118-13-8
Nomer CAT	RF-PI1103
Status Simpenan	Ing Simpenan, Kapasitas 30MT / Taun
Formula Molekul	C8H5BrS
Bobot Molekul	213.09
Merk	Kimia Ruifu

Spesifikasi:

Item	Spesifikasi
Penampilan	Bubuk Padat Kuning Muda
Kemurnian / Metode Analisis	> 97,0% (GC)
Spektrum Infra Merah	Conforms kanggo Struktur
NMR	Conforms kanggo Struktur
Standar Tes	Standar Perusahaan
Panggunaan	Intermediate saka Brexpiprazole (CAS: 913611-97-9)

Paket & Panyimpenan:

Paket: Botol, tas Aluminium foil, 25kg / Drum Karton, utawa miturut kabutuhan pelanggan

Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan

Kaluwihan:

FAQ:

Aplikasi:

4-Bromobenzo[b]thiophene (CAS: 5118-13-8) digunakake minangka perantara sintetik sing migunani, lan utamane diekspor menyang India, Amerika Utara, Korea, Jepang, lan Eropa.4-Bromobenzo[b]thiophene minangka perantara saka Brexpiprazole (CAS: 913611-97-9).Brexpiprazole disetujoni dening US Food and Drug Administration (FDA) tanggal 10 Juli 2015, kanggo perawatan skizofrenia, lan minangka perawatan tambahan kanggo depresi.Brexpiprazole wis dirancang kanggo nyedhiyakake khasiat lan toleransi sing luwih apik (contone, akathisia kurang, gelisah lan/utawa insomnia) liwat perawatan tambahan sing wis ditetepake kanggo kelainan depresi utama (MDD).Brexpiprazole, sing didol kanthi jeneng merek Rexulti antara liya, minangka antipsikotik atipikal.Brexpiprazole minangka agonis parsial reseptor dopamin D2 lan wis diterangake minangka "modulator aktivitas serotonin-dopamin" (SDAM).Brexpiprazole dikembangake dening Otsuka lan Lundbeck, lan dianggep minangka penerus aripiprazole antipsikotik atipikal Otsuka (Abilify).